Studying how glioblastoma returns and grows using patient blood and tumor samples
Collects blood and tumor samples from adults with glioblastoma to study how the disease returns.
Plain-language title generated from the registry record
Registry title: A Study to Better Understand the Biological and Molecular Mechanisms Involved in Glioblastoma Recurrence and Progression
Key facts
- Where
- Bordeaux, FranceSee the site
Where in France
- CHU de BordeauxBordeaux, FranceTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Hospital, Bordeaux
- Trial code
- NCT07173829
- Record updated
- 7 August 2026
- Original description
BORDEAUX-GLIO is a prospective, monocentric study which will describe the molecular, immune and metabolic pathways involved in the progression and relapse of glioblastoma, using blood and tumor samples from patients who have undergone surgery for newly diagnosed or recurrent glioblastoma in the center.Read full original descriptionShow less
A Prospective Study to Better Understand the Molecular, Immune and Metabolic Mechanisms Involved in Glioblastoma Recurrence and Progression, in the Aim to Identify New Therapeutic Targets and to Improve Current Therapies
BORDEAUX-GLIO is a prospective, monocentric study which will describe the molecular, immune and metabolic pathways involved in the progression and relapse of glioblastoma, using blood and tumor samples from patients who have undergone surgery for newly diagnosed or recurrent glioblastoma in the center.
Inclusion: Patients of 18 years or older, with highly suspected glioblastoma on neuro-imagery; Planned surgical tumor resection,; No objection to participate in research; Signed genetic consent.
Exclusion: Patients deprived of their liberty by judicial or administrative decision, or under psychiatric care; Patients under guardianship, curatorship or protective supervision; Taking immunosuppressants; Pregnant or breast-feeding women.